HMSA Pharmacy Newsletter April 2006 For Participating Medical Practitioners
|
|
- Madeleine Whitehead
- 5 years ago
- Views:
Transcription
1 For Participating Medical Practitioners CDC HEALTH ALERT - USE OF ANTIVIRALS FOR INFLUENZA The U.S. Centers for Disease Control and Prevention (CDC) issued a Health Alert on January 14, 2006 regarding the use of antivirals for the treatment of influenza. For the season, influenza A (H3N2) viruses isolated from 120 patients in 23 states have been tested at CDC and 109 (91 percent) found to be resistant to amantadine and rimantadine. However, all influenza viruses found across the United States screened for antiviral resistance at CDC as of January 14 demonstrated susceptibility to the neuraminidase inhibitors oseltamivir and zanamivir. On the basis of these results, CDC is providing an interim recommendation that neither amantadine (Symmetrel) nor rimantadine (Flumadine) be used for the treatment or prophylaxis of influenza for the remainder of the influenza season. During this period, oseltamivir (Tamiflu) and zanamivir (Relenza) should be selected if an antiviral medication is used for the treatment of influenza, or oseltamivir (Tamiflu) should be prescribed for chemoprophylaxis of influenza. CDC recommends that neuraminidase inhibitors (oseltamivir and zanamivir) be used as treatment for any person experiencing a potentially life-threatening influenza-related illness and for persons at high risk for serious complications from influenza. Annual influenza vaccination remains the primary means of preventing morbidity and mortality associated with influenza. New Generics Remember to check here for information on newly available generics. Generic name azithromcycin clindamycin, vaginal cream glimepiride glipizide/metformin halobetasol leflunomide ribavirin Brand name equivalent Zithromax Cleocin, vaginal cream Amaryl Metaglip Ultravate Arava Copegus FORMULARY ADDITIONS The drugs listed below will have the status of PREFERRED for the Select plan, TIER 2 for HMSA s 65C Plus Prescription Drug Coverage and FORMULARY for The HMSA Plan for QUEST Members: cefdinir (Omnicef) effective April 1, 2006 fenofibrate (Lofibra) effective January 1, 2006 valganciclovir (Valcyte) effective April 1, 2006 Inside this Issue QUEST injectables...2 New medication management program...2 HHIN dial-up discontinued...2 Drug updates...3 Reminders...3 Formulary update...4 Contact information...4 PM06-004
2 PRECERTIFICATION REQUIRED FOR QUEST INJECTABLES The injectables listed below require precertification and have been processing incorrectly at point-of-sale. A correction has been made to HMSA s drug claims processor; effective February 1, 2006, these drugs deny at point-of-sale if a pre-certification has not been approved for QUEST members. Actimmune IVIG Carimune, Flebogamma, Gamimune N, Gammagard S/D, Gammar PI.V., Gamunex, Iveegam EN, Panglobulin, Polygam S/D, Venoglobulin-S Amevive Amino acids Aminosyn, Clinimix, Freamine, Hepatamine, Procalamine, Trophamine Amrinone Avastin Byetta Dobutamine Dopamine Erbitux Forteo Growth Hormone Genotropin, Humatrope, Norditropin, Nutropin AQ, Nutropin Depot, Protropin, Saizen, Serostim Intralipids Lupron Milrinone Pegasys Pegintron Raptiva Rebetron Remicade Synagis Velcade Xolair Zevalin MEDICATION THERAPY MANAGEMENT PROGRAM COMING SOON! The Medication Therapy Management (MTP) Program for HMSA s 65C Plus Prescription Drug Coverage Plan is coming soon. We will be recruiting a provider network shortly in preparation for a program launch date of May 1, Physicians with eligible patients will be receiving information on the program in April. HHIN DIAL-UP ACCESS TO BE DISCONTINUED Effective May 1, 2006, the Hawaii Healthcare Information Network (HHIN) will no longer be accessible through direct dial-up connections. If you are currently an HHIN dial-up user, we urge you to convert to HHIN Internet service prior to May 1. If you are not currently an HHIN subscriber, we encourage you to sign up for free HHIN Internet service. With HHIN, you can quickly and efficiently obtain eligibility, claims, TAD and benefit information online. In addition, you can enter referral information and access HMSA's Provider E-Library and other references. To start HHIN Internet service, please contact HHIN's support staff at For existing HHIN users, please call on Oahu or 1 (800) from the Neighbor Islands. DRUG UPDATES 2
3 LOFIBRA (fenofibrate) ADDED TO FORMULARY On January 1, 2006, Lofibra (fenofibrate) was added to the HMSA Formulary as a PREFERRED drug for Select plan members, TIER 2 for 65C Plus Prescription Drug Coverage and as a FORMULARY drug for QUEST plan members. Lofibra is available in 67, 134 and 200 MG micronized capsules as well as 54 and 160 MG micro-coated tablets. The most commonly prescribed fenofibrate in the formulary has been Tricor, which is classified as an OTHER BRAND drug for the Select Plan and NON-FORMULARY for the QUEST plan. Lofibra is approved by the FDA as therapeutically equivalent to and has the same safety profile as Tricor, and will result in a lower copayment for SELECT Plan members. TRIPTAN QUANTITY LIMIT CHANGES EFFECTIVE JANUARY 1, 2006 Maxalt, Maxalt MLT 9 tablets per 30 days Zomig nasal spray 6 sprays per 30 days Pre-certification is required when a physician wishes to prescribe quantities exceeding the limits. NDC CLARIFICATION Providers should be aware that if there are multiple NDCs for a drug and any of the NDCs are classified as unit dose drugs, those drugs may deny as an exclusion for private business and The HMSA Plan for QUEST Members as applicable. LEVEMIR Although Levemir (insulin detemir) is used to treat diabetes, it is not classified at the same benefit level as other insulins for the Select, 65C Plus Prescription Drug Coverage and QUEST plans. Levemir will be a benefit for drug riders that currently cover insulin. It is classified as OTHER BRAND for private business plans, TIER 3 for HMSA s 65C Plus Prescription Drug Coverage plan, GENERIC for Choice and Non-Formulary plans and NON-FORMULARY for QUEST. The expected launch for Levemir is late March or early April Levemir will be available in two forms: FlexPen and vial. REMINDERS NIASPAN EXCLUSIONS In the last newsletter, we notified providers that Niaspan was no longer a benefit of the Medicare Discount Drug Card (MDDC) program. This exclusion also applies to HMSA s 65C Plus Prescription Drug Coverage plan. 3
4 FIXED DIFFERENTIAL FOR OTHER BRAND DRUGS Effective January 1, 2006, a fixed differential of $35 per 30 days for OTHER BRAND drugs was implemented for all Select plans except Federal Plan 87 (00F), Hawaii Employer-Union Health Benefits Trust Fund (00S) and coverage codes 395 and 396. Having the fixed differential in place gives the members predictability when purchasing OTHER BRAND drugs. The members out-of-pocket cost will be equal to their PREFERRED brand copayment plus the fixed differential of $35 per 30 days. Copayments may vary between 2005 and 2006 for the same members as a result of the fixed differential implementation. Previously, the differential was calculated as the average Eligible Charge of generics and preferred drug products within the same therapeutic class for a given OTHER BRAND drug product. Effective January 1, 2006, the fixed differential of $35 is the difference between the average Eligible Charge of OTHER BRAND name drugs and the average Eligible Charge of GENERIC and PREFERRED drugs covered by the association. This $35 is applied to all drugs classified as OTHER BRAND and is the amount the member is responsible for in addition to the member s PREFERRED brand copayment. For dual membership claims (HMSA commercial plan as the primary and secondary plan), if the member receives an OTHER BRAND drug, the secondary plan will coordinate benefits. However, in many cases, the member will still be responsible for the $35 fixed differential. HMSA S 65C PLUS PRESCRIPTION DRUG COVERAGE INFORMATION AVAILABLE ONLINE Helpful information on HMSA s new CMS-approved plan is available online in the Pharmacy Handbook section of the Provider E-Library. HMSA FORMULARY UPDATE Enclosed is the HMSA Formulary update. Please include it with your formulary reference material. The formulary is available on HHIN and the Internet at Formulary changes referred to in this newsletter will not be reflected in the online formulary until the effective date of the changes. Updated condition codes, including 65C Plus Prescription Drug Coverage, will also be available online on April 1 in the Formulary section of the E-Library. A printable version is also available in the same section. CONTACT INFORMATION Questions or comments regarding the HMSA Drug Formulary revisions may be directed to: Kris Tsutomi, R.Ph. HMSA Pharmacy Management P.O. Box 860 Honolulu, HI
5 For routine claims and eligibility questions, we encourage you to use HHIN. Other questions should be directed to the applicable phone number below: HMSA Provider Teleservice Representatives at on Oahu or 1 (800) from the Neighbor Islands HMSA Membership Connection (touch-tone eligibility verification) on Oahu at or 1 (800) from the Neighbor Islands The HMSA Plan for QUEST Members Provider Services at on Oahu or 1 (800) from the Neighbor Islands Members with questions or concerns regarding their HMSA drug plans may call an HMSA Customer Service representative at the following numbers: Oahu Kauai Hilo Maui, Lanai, Molokai Kona QUEST members who have questions or concerns may call QUEST Member Services at on Oahu or 1 (800) from the Neighbor Islands. 5
HMSA Pharmacy Newsletter February
HMSA s HMSA Pharmacy Newsletter February 2006 www.hmsa.com/portal/provider CDC HEALTH ALERT - USE OF ANTIVIRALS FOR INFLUENZA The U.S. Centers for Disease Control and Prevention (CDC) issued a Health Alert
More informationHMSA Formulary Newsletter August 2004
HMSA Formulary Newsletter August 2004 FILING 65C PLUS DRUG CLAIMS - UPDATE In a memo dated June 25, 2004, participating pharmacies were instructed to use condition code 33330 in the prior authorization
More informationAnnual Eye Exams Part of Diabetic Care
For Participating Medical Practitioners January 2005 Annual Eye Exams Part of Diabetic Care More than 47,000 HMSA members have been diagnosed with diabetes. Diabetic retinopathy is the leading cause of
More informationPrescription Drug Benefit Rider
Prescription Drug Benefit Rider Your Certificate of Coverage is amended as described in this document. This Rider becomes a part of your Certificate of Coverage and is subject to all provisions of your
More informationPrescription Drug Benefit Rider V
Prescription Drug Benefit Rider V Your Certificate of Coverage is amended as described in this document. This Rider becomes a part of your Certificate of Coverage and is subject to all provisions of your
More informationIdaho DUR Board Meeting Minutes
Idaho DUR Board Meeting Minutes Date: Jan. 16, 2014 Time: 9am-1pm Location: Idaho Medicaid, 3232 Elder Street, Boise, Idaho, Conference Room D-West Moderator: Mark Turner, M.D. Committee Member Present:
More informationFREQUENTLY ASKED QUESTIONS SWINE FLU
FREQUENTLY ASKED QUESTIONS SWINE FLU Updated 5/6/09 ER FAQ What is swine flu? Swine flu is common disease of pigs and is caused by the same category of influenza virus (influenza A) that causes flu in
More informationNew CMS 1500 Claim Form
For Participating Medical Pharmacies March 2007 CMS 1500 Claim Form HMSA is able to process paper claims submitted on the new CMS 1500 form. However, providers may continue to submit paper claims on the
More informationTamiflu. Tamiflu (oseltamivir) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.01.19 Subject: Tamiflu Page: 1 of 5 Last Review Date: March 18, 2016 Tamiflu Description Tamiflu (oseltamivir)
More informationRevised Recommendations for the Use of Influenza Antiviral Drugs
QUESTIONS & ANSWERS Revised Recommendations for the Use of Influenza Antiviral Drugs Background On September 8, 2009 CDC updated its recommendations for the use of influenza antiviral medicines to provide
More informationThe pages that follow contain information critical to protecting the health of your patients and the citizens of Colorado.
Health Alert Network Tri-County Health Department Serving Adams, Arapahoe and Douglas Counties Phone 303/220-9200 Fax 303/741-4173 www.tchd.org Follow us on Twitter @TCHDHealth and @TCHDEmergency John
More informationWhat Antivirals Can Be Used for 2009 H1N1 Influenza?
www.upmc-biosecurity.org www.upmc-cbn.org May 13, 2009 The Use of Antivirals for 2009 H1N1 Influenza Virus Infection By Ann Norwood, MD, Brooke Courtney, JD, MPH, Eric Toner, MD, and Amesh Adalja, MD Use
More informationHMSA Welcomes Employees
HMSA s For Participating Medical Practitioners November 2012 What s Inside Got No Time? Go Online! 2 By the Numbers 3 Electronic 3 Procedures 4 Policy News 5 TRICARE 7 HMSA Welcomes Employees of The Queen
More informationHMSA Provider Bulletin
HMSA Provider Bulletin T H E H M S A P L A N F O R Q U E S T M E M B E R S Bulletin Q09-06 December 1, 2009 Seasons greeting to you and your staff! As the holidays approach, we look forward to the many
More informationHuman Cases of Influenza A (H1N1) of Swine Origin in the United States and Abroad Updated Key Points April 29, 2008: 9:58AM
Situation Update CDC is reporting 91 human infections with this influenza A (H1N1) virus of swine origin in the United States. (An increase in 27 over the number of cases reported yesterday.) The list
More informationNEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE Thomas R. Frieden, MD, MPH Commissioner
NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE Thomas R. Frieden, MD, MPH Commissioner Interim Guidance on Dosage, Precautions, and Adverse Effects of Antiviral Medications used to Treat or Prevent
More informationFlu Vaccine for Season
For Participating Medical Practitioners October 2006 Flu Vaccine for 2006-2007 Season The U.S. Food and Drug Administration (FDA) licensed four manufacturers to produce flu vaccine for the 2006-2007 flu
More information$250 (Deductible does not apply to Tier 1 and Tier 2) $500 (Deductible does not apply to Tier 1 and Tier 2)
Benefit Summary Outpatient Prescription Drug Illinois 5/50/100/250 Plan 455 Your Co-payment and/or Co-insurance is determined by the tier to which the Prescription Drug List (PDL) Management Committee
More informationFlexRx 6-Tier. SM Pharmacy Benefit Guide
FlexRx 6-Tier SM Pharmacy Benefit Guide Welcome to FlexRx The AllWays Health Partners FlexRx SM program is built for choice, savings, and convenience with benefits including: Low-cost drug tier for many
More informationDescriptor Brand Name. Alprostadil, Caverject, Edex, Prostin VR Pediatric. Calcimar, Miacalcin
Self-Administered Drug Exclusion List R2 This article from Medicare A News, Issue 2106 dated January 23, 2013 and Medicare B News, Issue 283 dated January 23, 2013 is being revised to add Acthar ACTH gel
More information1, 2014 PHARMACY BENEFIT
Effective 01/01/2007City of Plano Employee Benefit Design Summary Effective Date: January 1, 2014 PHARMACY BENEFIT CVS/CAREMARK TOLLFREE: 888-850-8245 ID CARD & NETWORK PHARMACIES: Identification Card
More informationSTATE OF HAWAII DEPARTMENT OF HEALTH P.O Box 3378 Honolulu, Hawaii August 1, 2009
LINDA LINGLE GOVERNOR OF HAWAII CHIYOME LEINAALA FUKINO, M.D. DIRECTOR OF HEALTH STATE OF HAWAII DEPARTMENT OF HEALTH P.O Box 3378 Honolulu, Hawaii 96801-3378 August 1, 2009 Dear Parents: The Hawai i State
More informationAnti-Influenza Agents Quantity Limit Program Summary
Anti-Influenza Agents Quantity Limit Program Summary FDA APPROVED INDICATIONS DOSAGE 1,2 Agent Indication Dosage & Administration Relenza Treatment of influenza in Treatment of influenza: (zanamivir) patients
More informationPharmacy and Medical Guideline Updates
STAT Bulletin PO Box 15013 Albany, New York 12212 August 2, 2010 Volume 8: Issue 19 To: All PCPs and Specialists Contracts Affected: All Lines of Business Pharmacy and ical Guideline Updates As a result
More informationHEALTH ALERT SWINE INFLUENZA SITUATION UPDATE UPDATED PATIENT TESTING PRIORITIZATION INTERIM GUIDANCE ON ANTIVIRALS
HEALTH ALERT SWINE INFLUENZA SITUATION UPDATE UPDATED PATIENT TESTING PRIORITIZATION INTERIM GUIDANCE ON ANTIVIRALS DATE: May 7, 2009 TO: Physicians, Providers, and Pharmacists in San Joaquin County FROM:
More informationPharmacy benefit guide
FlexRx SM 5-Tier Pharmacy benefit guide 1 Welcome to FlexRx The NHP FlexRx SM program is built for choice, savings, and convenience with benefits including: Low-cost drug tier for many common medications
More informationDear Member: We look forward to serving you. Sincerely, Express Scripts
Dear Member: Welcome to Express Scripts, the company Eastern Kentucky University has chosen to manage your prescription drug plan. As one of the nation s leading prescription benefit managers, Express
More informationFederal Employees Health Benefits Program. HMSA s Federal Plan 87
Federal Employees Health Benefits Program HMSA s Federal Plan 87 We ve got you covered Freedom to choose your own doctors Access to a large provider network of doctors and hospitals Convenient care at
More informationCoventry Health Care of Georgia, Inc.
Coventry Health Care of Georgia, Inc. PRESCRIPTION DRUG RIDER (for High Deductible Health Plans) This Prescription Drug Rider is an attachment to the Coventry Health Care of Georgia, Inc. ( Health Plan
More informationInfluenza Therapies. Considerations Prescription influenza therapies require prior authorization through pharmacy services.
Influenza Therapies Policy Number: 5.01.515 Last Review: 10/2017 Origination: 10/2002 Next Review: 10/2018 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage for influenza
More informationInfluenza Outbreaks. An Overview for Pharmacists Prescribing Antiviral Medications
Influenza Outbreaks An Overview for Pharmacists Prescribing Antiviral Medications Under the Collaborative Drug Therapy Agreement for Influenza Antiviral Medications Learning Objectives 1. Understand the
More informationSection 10. How To Identify Members. In This Section
Section 10 How To Identify Members In This Section Page Highmark Blue Shield Members 10-1 Verifying Eligibility For A Highmark Blue Shield Member 10-1 Out-Of-Area (BlueCard ) Members 10-1 Verifying Eligibility
More informationAntivirals for Avian Influenza Outbreaks
Antivirals for Avian Influenza Outbreaks Issues in Influenza Pandemic Preparedness 1. Surveillance for pandemic preparedness eg. H5N1 2. Public health intervention eg. efficacy, feasibility and impact
More informationInfluenza Exposure Medical Response Guidance for the University of Wisconsin-Madison
Influenza Exposure Medical Response Guidance for the University of Wisconsin-Madison 1.0 Instructions: Information in this guidance is meant to inform both laboratory staff and health professionals about
More informationClinical Guidance for 2009 H1N1 Influenza and Seasonal Influenza. Barbara Wallace, MD New York State Department of Health (Updated 10/8/09)
Clinical Guidance for 2009 H1N1 Influenza and Seasonal Influenza Barbara Wallace, MD New York State Department of Health (Updated 10/8/09) 1 Outline Clinical assessment Diagnostic testing Antiviral medications
More informationCongregate Care Facilities
Congregate Care Facilities Information for Pierce County Long-Term Care Facilities vember 2017 Influenza Outbreak Guidelines Reporting Requirements Communicable Disease Division 3629 South D Street, Tacoma,
More informationWhat s in this issue: EDITION MEDICARE MEMBER NEWSLETTER
MEDICARE MEMBER NEWSLETTER F A L L EDITION What s in this issue: www.bcidaho.com/medicare Watch your mailbox - Important plan information is arriving soon NEW! Mind Games. Keep your brain sharp. Improved
More informationPart D Pharmacy. An Independent Licensee of the Blue Cross Blue Shield Association ( )
Part D Pharmacy 1 An Independent Licensee of the Blue Cross Blue Shield Association 044507 (12-21-2017) New MA pharmacy partner We ve selected CVS Caremark to manage our part D pharmacy benefits Providence
More informationInfluenza RN.ORG, S.A., RN.ORG, LLC
Influenza WWW.RN.ORG Reviewed May, 2017, Expires May, 2019 Provider Information and Specifics available on our Website Unauthorized Distribution Prohibited 2017 RN.ORG, S.A., RN.ORG, LLC PURPOSE: This
More informationPolicy: Growth Hormones Reference Number: TCHP.PHAR.184 Effective Date: Last Review Date:
Policy: Growth Hormones Reference Number: TCHP.PHAR.184 Effective Date: 07.01.2018 Last Review Date: 04.13.2018 Line of Business: Medicaid Revision Log See Important Reminder at the end of this policy
More informationA BULLETIN FOR PHARMACY SERVICE PROVIDERS FROM ALBERTA BLUE CROSS
Pharmacy Benefact A BULLETIN FOR PHARMACY SERVICE PROVIDERS FROM ALBERTA BLUE CROSS Number 757 September 2018 Alberta Public Health Activities Program (APHAP) Influenza Immunization Program 2018/2019 This
More informationDuring Influenza Season A Checklist for Residential Care Facilities
During Influenza Season A Checklist for Residential Care Facilities Seasonal influenza is a serious cause of illness, disability and death in residents of care facilities. Each year, across Canada there
More informationGROWTH HORMONE THERAPY
GROWTH HORMONE THERAPY Line(s) of Business: HMO; PPO; QUEST Integration Original Effective Date: 05/21/1999 Current Effective Date: 10/01/2015 POLICY A. INDICATIONS The indications below including FDA-approved
More informationPANDEMIC INTERVENTIONS WEIGHING THE OPTIONS TO PROTECT YOUR WORKFORCE
PANDEMIC INTERVENTIONS WEIGHING THE OPTIONS TO PROTECT YOUR WORKFORCE Presented by Dr. Allan Holmes President, Global Medical Services / Global Consulting PRESENTATION OBJECTIVES Pandemic still a threat
More informationFPIN's Clinical Inquiries. What Is the Best Antiviral Agent for Influenza Infection? Searchable Question
FPIN's Clinical Inquiries What Is the Best Antiviral Agent for Influenza Infection? Searchable Question What is the best antiviral treatment for influenza? Evidence-Based Answer Four antiviral agents have
More informationDrugs That Require Step Therapy (ST)
Saver Drugs That Require Step Therapy (ST) In some cases, Express Scripts Medicare (PDP) requires you to first try certain drugs to treat your medical condition before we will cover another drug for that
More informationUnitedHealthcare Enrollment Service Area Nationwide. UnitedHealthcare Group
UnitedHealthcare v UnitedHealthcare Enrollment Service Area Nationwide UnitedHealthcare Group The Value of UnitedHealthcare and the PHIP Partnership National coverage that follows you where ever you are
More informationSTAT Bulletin. Drug Therapy Guideline Updates. To: All Primary Care Physicians and Specialists Contracts Affected: All Lines of Business
STAT Bulletin November 28, 2011 Volume 17: Issue 34 To: All Primary Care Physicians and Specialists Contracts Affected: All Lines of Business Drug Therapy Guideline Updates Why you re receiving this Stat
More informationINFLUENZA (Outbreaks; hospitalized or fatal pediatric cases)
INFLUENZA (Outbreaks; hospitalized or fatal pediatric cases) 1. Agent: Influenza viruses A, B, and C. Only influenza A and B are of public health concern since they are responsible for epidemics. 2. Identification:
More informationGROWTH HORMONE THERAPY
GROWTH HORMONE THERAPY Line(s) of Business: HMO; PPO; QUEST Integration Original Effective Date: 05/21/1999 Current Effective Date: 12/30/201601/01/2018TBD03/01/2018 POLICY A. INDICATIONS The indications
More informationUnitedHealthcare Enrollment Service Area Nationwide. UnitedHealthcare Group
UnitedHealthcare v UnitedHealthcare Enrollment Service Area Nationwide UnitedHealthcare Group The Value of UnitedHealthcare and the PHIP Partnership National coverage that follows you where ever you are
More informationGROWTH HORMONE THERAPY
GROWTH HORMONE THERAPY Line(s) of Business: HMO; PPO; QUEST Integration Original Effective Date: 05/21/1999 Current Effective Date: 03/01/201804/01/2019 POLICY A. INDICATIONS The indications below including
More informationDrugs That Require Step Therapy (ST)
Choice Drugs That Require Step Therapy (ST) In some cases, Express Scripts Medicare (PDP) requires you to first try certain drugs to treat your medical condition before we will cover another drug for that
More informationPeramivir IV Questions and Answers for Health Care Providers
Drugs Peramivir IV Questions and Answers for Health Care Providers Q1. What action is FDA taking regarding Peramivir IV? A. As part of the federal government s response to the 2009 H1N1 public health emergency,
More informationDrugs That Require Step Therapy (ST)
Saver Drugs That Require Step Therapy (ST) In some cases, Express Scripts Medicare (PDP) requires you to first try certain drugs to treat your medical condition before we will cover another drug for that
More information2016 Travelers Prescription Drug Plan Blue Cross Blue Shield Plan and United Healthcare Choice Plus Plan
2016 Travelers Prescription Drug Plan Blue Cross Blue Shield Plan and United Healthcare Choice Plus Plan Plan Details, Programs, and Policies Table of Contents Click on the links below to be taken to that
More informationSTAT Bulletin. Drug Therapy Guideline Updates. To: All Primary Care Physicians and Specialists Contracts Affected: All Lines of Business
STAT Bulletin November 28, 2011 Volume 9: Issue 27 To: All Primary Care Physicians and Specialists Contracts Affected: All Lines of Business Drug Therapy Guideline Updates Why you re receiving this Stat
More informationSwine Influenza Update #3. Triage, Assessment, and Care of Patients Presenting with Respiratory Symptoms
Updated 12:00 p.m. April 30, 2009 Swine Influenza Update #3 Introduction: This document revises our last update which was sent April 28 th, 2009. The most important revisions include the following: 1.
More informationInfluenza Update for Iowa Long-Term Care Facilities. Iowa Department of Public Health Center for Acute Disease Epidemiology
Influenza Update for Iowa Long-Term Care Facilities Iowa Department of Public Health Center for Acute Disease Epidemiology Webinar Information All participants will be muted during the presentation. Questions
More informationDental Fee Schedule Updated
For Participating Dentists August 2004 Dental Fee Schedule Updated HMSA is pleased to announce that all fees for covered dental services will receive a 2.3 percent increase across the board effective October
More information1 Criteria for triggering the use (both start-up and stoppage) of neuraminidase inhibitors by clinicians for the treatment of influenza in the UK
HPA submission to NICE for the assessment of zanamivir, oseltamivir and amantadine for the treatment of influenza (an update review of existing guidance No. 58). February 2008 1 Criteria for triggering
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: (Xofluza) Reference Number: CP.PMN.185 Effective Date: 10.30.18 Last Review Date: 11.18 Line of Business: Commercial, Medicaid Revision Log See Important Reminder at the end of this policy
More informationPHARMACY BENEFITS MANAGER
PHARMACY BENEFITS MANAGER CU GME Benefits Office Prescriptions should be obtained at participating pharmacies using your Benefits ID card. A list of participating pharmacies may be obtained by calling
More informationMedicare Part D Opioid Policies for 2019 Information for Patients
CENTERS FOR MEDICARE & MEDICAID SERVICES Medicare Part D Opioid Policies for 2019 Information for Patients Introduction Prescription opioid pain medications like oxycodone (OxyContin ), hydrocodone (Vicodin
More informationInfant and Pediatric Influenza. Mike Czervinske RRT-NPS University of Kansas Medical Center
Infant and Pediatric Influenza Mike Czervinske RRT-NPS University of Kansas Medical Center Influenza Infants and Influenza Acute infection of the respiratory tract Nose Throat Possibly lungs Pathophysiology
More informationCARD/MAIL/PRE-APPROVAL/PREFERRED RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date:
RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date: CARD/MAIL/PRE-APPROVAL/PREFERRED The Prescription Drug Coverage under this Rider [replaces] [supplements] the Prescription
More informationA new code for this year! G9153
SM www.bluechoicescmedicaid.com Volume 5, Issue 1 February 2017 2017 Incentive Payments: A new code for this year! G9153 The South Carolina Department of Health and Human Services (SCDHHS) has identified
More informationLEVEMIR (insulin detemir) subcutaneous solution LEVEMIR FLEXTOUCH (insulin detemir) subcutaneous solution pen-injector
LEVEMIR FLEXTOUCH (insulin detemir) subcutaneous solution pen-injector Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific
More informationDecember 22, Health Care Providers, Hospitals, Long Term Care Facilities, and Local Health Departments
December 22, 2009 To: Health Care Providers, Hospitals, Long Term Care Facilities, and Local Health Departments From: NYSDOH Division of Epidemiology HEALTH ADVISORY: UPDATED CLINICAL GUIDANCE FOR HEALTH
More informationWatch out, flu season is here
D. Gary Benfield, M.D. Talking to myself about this winter s flu season: I: Tell me, old swami, what do you think about this flu season so far? Me: You want the long answer or the short answer? I: Make
More informationPayment Transformation 2018 Measure Changes and Updates. June 27, 2018
Payment Transformation 2018 Measure Changes and Updates June 27, 2018 A G E N D A 1. 2018 Performance Measures 2. News & Updates 3. 2018 Engagement Measures 4. Patient Attribution & Panel Management Cozeva
More informationHARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES
Generic Brand HICL GCN Exception/Other SOMATROPIN HUMATROPE GENOTROPIN NORDITROPIN NORDITROPIN FLEXPRO NORDITROPIN NORDIFLEX NUTROPIN NUTROPIN AQ OMNITROPE SAIZEN ZOMACTON 02824 BRAND ZORBTIVE BRAND SEROSTIM
More informationInfluenza Update. Kelly L. Moore, MD, MPH Medical Director, Immunization Program TN Department of Health TPHA Epi Section September 3, 2009
2009-2010 Influenza Update Kelly L. Moore, MD, MPH Medical Director, Immunization Program TN Department of Health TPHA Epi Section September 3, 2009 Outline Epidemiology to date What to do until vaccine
More information2009 / 2010 H1N1 FAQs
The information contained within this document was compiled from sources that include the Center for Disease Control and Prevention (CDC), U.S. Department of Health and Human Services, and the Oregon Department
More informationPrior Authorization Required: Yes as shown below
PROLIA, XGEVA (denosumab) MB9409 Covered Service: Prior Authorization Required: Additional Information Medicare Policy: BadgerCare Plus Policy: Yes when meets criteria below Yes as shown below Must be
More informationCongregate Care Facilities
Congregate Care Facilities Information for Pierce County Long-Term Care Facilities Oct. 2015 Influenza Outbreak Guidelines Reporting Requirements Communicable Disease Division 3629 South D Street, Tacoma,
More information2018 Travelers Prescription Drug Plan High Deductible + HSA Plan
2018 Travelers Prescription Drug Plan High Deductible + HSA Plan Plan Details, Programs, and Policies Table of Contents Click on the links below to be taken to that section National Preferred Formulary
More informationGetting started with Prime
Getting started with Prime How does a pharmacy plan work? When you visit your doctor, he or she may prescribe medicine for you. Here's how the plan works: Take your prescription and member ID card to the
More informationNovel H1N1 Influenza A Update. William Muth MD 2 Oct 2009
Novel H1N1 Influenza A Update William Muth MD 2 Oct 2009 Novel H1N1 Influenza A Update Epidemiology Treatment Chemoprophylaxis Vaccine Infection Prevention Novel H1N1 Influenza A International Epidemiology
More informationClass Update with New Drug Evaluation: Influenza Antiviral Agents
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationHumatrope*, Norditropin*, Genotropin, Nutropin, Nutropin AQ, Omnitrope, Saizen
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.30.11 Subject: Growth Hormone Adult Page: 1 of 6 Last Review Date: December 8, 2017 Growth Hormone Adult
More informationAVIAN FLU BACKGROUND ABOUT THE CAUSE. 2. Is this a form of SARS? No. SARS is caused by a Coronavirus, not an influenza virus.
AVIAN FLU BACKGROUND 1. What is Avian Influenza? Is there only one type of avian flu? Avian influenza, or "bird flu", is a contagious disease of animals caused by Type A flu viruses that normally infect
More informationPage: 1 of 5. Sumatriptan Tablets and Nasal Spray (Imitrex) / sumatriptan and naproxen sodium (Treximet tablets)
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 0 Subject: Sumatriptan (Imitrex / Treximet) Page: 1 of 5 Last Review Date: September 12, 2014 Sumatriptan
More informationHumatrope*, Norditropin*, Genotropin, Nutropin, Nutropin AQ, Omnitrope, Saizen
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.08.11 Subject: Growth Hormone Adult Page: 1 of 6 Last Review Date: September 15, 2016 Growth Hormone
More informationHumatrope*, Norditropin*, Genotropin, Nutropin, Nutropin AQ, Omnitrope, Saizen, Zomacton
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.30.11 Subject: Growth Hormone Adult Page: 1 of 6 Last Review Date: September 20, 2018 Growth Hormone
More informationSupporting our provider partners through communication and collaboration. Formulary Updates
Supporting our provider partners through communication and collaboration. DATE DECEMBER 2014 ISSUE 4 HELPFUL NUMBERS FOR PROVIDERS Passport Health Plan Magellan: 1-800-846-7971 Bin: 016523 Processor control:
More informationAETNA BETTER HEALTH OF ILLINOIS Provider Newsletter August 2016, Vol. 5
AETNA BETTER HEALTH OF ILLINOIS Provider Newsletter August 2016, Vol. 5 www.aetnabetterhealth.com/illinois With questions or concerns, please contact Provider Services at 866-212-2851 Option 2 Diabetes
More informationEnsuring an Adequate Stockpile of Antivirals. Paul Brown F. Hoffmann La-Roche Basel, Switzerland
Ensuring an Adequate Stockpile of Antivirals Paul Brown F. Hoffmann La-Roche Basel, Switzerland Vaccines and Antivirals Vaccines provide the best prevention option But there are limitations: Time from
More informationAlberta Health. Seasonal Influenza in Alberta Season Summary
Alberta Health Seasonal Influenza in Alberta 217 218 Season Summary September 218 Seasonal Influenza in Alberta, 217-218 Season Summary September 218 Suggested Citation: Government of Alberta. Seasonal
More informationInfluenza: Seasonal, Avian, and Otherwise
Influenza: Seasonal, Avian, and Otherwise Lisa Winston, MD University of California, San Francisco San Francisco General Hospital Influenza biology Antiviral medications Seasonal influenza Vaccination
More informationSituation Update Pandemic (H1N1) August 2009
Situation Update Pandemic (H1N1) 2009 31 August 2009 Timeline pandemic (H1N1) 2009 April 12: an outbreak of influenza-like illness in Veracruz, Mexico reported to WHO April 15-17: two cases of the new
More informationThe Weekly Mortar & Pestle
The Weekly Mortar & Pestle A Publication of Walgreens Health Initiatives The accuracy and completeness of the content herein are not guaranteed by Walgreen Co. or its affiliates and subsidiaries. Content
More informationCoverage Period: Coverage for: Plans: This is only a summary of your GatorCare pharmacy benefits. Coinsurance: you your Dependent Copayment: you
This is only a summary of your GatorCare pharmacy benefits. If you would like detail about your coverage and costs, you can get the complete terms in the policy or plan document at gatorcare.magellanrx.com/member
More informationINTERNATIONAL SOCIETY FOR HEART AND LUNG TRANSPLANTATION a Society that includes Basic Science, the Failing Heart, and Advanced Lung Disease
International Society of Heart and Lung Transplantation Advisory Statement on the Implications of Pandemic Influenza for Thoracic Organ Transplantation This advisory statement has been produced by the
More informationCDC Health Advisory 04/29/2009
H1N1 (Swine Flu) is a sub-type of Influenza A. Wexford Labs disinfectants are effective against Influenza A. Current CDC Recommendations for Environmental Control in the Healthcare Setting: CDC Health
More informationVaccine Starter Kit Program FAQs
Vaccine Starter Kit Program FAQs Program How does this program help Health Mart pharmacies provide vaccines for their customers? McKesson has designed a comprehensive program specifically for Health Mart
More information